Brainomix and TIPAL partner to assess e-Lung platform
The platform helps standardise the quantification of lung fibrosis on high resolution CT scans to detect progressive fibrosis.
11 September 2023
11 September 2023
The platform helps standardise the quantification of lung fibrosis on high resolution CT scans to detect progressive fibrosis.
The company offers the needle in 21G, 22G and 25G configurations.
The point-of-care device would reduce the antibiotic susceptibility testing time from days to minutes.
The study will be registered as per the International Committee of Medical Journal Editors requirements.
In the wake of this controversy, the medical device industry may face heightened scrutiny and regulatory changes.
Patients reported that they no longer needed glasses to see at arm’s length and far away.
Lord James O’Shaughnessy talks to the Clinical Trials Arena team about his review of commercial clinical trials in the UK and the path the country can take to recovery.
The Arena International Outsourcing in Clinical Trials UK and Ireland discussed how the UK’s clinical trial landscape has taken a hit and what improvements are needed to make it a more viable country for research.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.
Give your business an edge with our leading industry insights.